J Trauma. 2003 Jun;54(6):1111-5. doi: 10.1097/01.TA.0000042159.90102.C2.
This prospective, multicenter study compared low-dose unfractionated heparin (UFH) with enoxaparin for prophylaxis against venous thromboembolism (VTE) during the rehabilitation phase after spinal cord injury.
After 2 weeks of acute-phase prophylaxis, patients without objective evidence of VTE entered the rehabilitation phase and received up to 6 additional weeks of thromboprophylaxis with either UFH 5,000 U every 8 hours or enoxaparin 40 mg once daily. Patients then underwent repeat bilateral lower extremity duplex ultrasonography.
Among 119 patients who completed the rehabilitation phase and had adequate imaging, new VTE was demonstrated in 13 of 60 UFH versus 5 of 59 enoxaparin patients (21.7% vs. 8.5%; p = 0.052). Only one patient from each group was discontinued from the study because of bleeding.
In this nonrandomized comparison, enoxaparin appeared more effective than heparin in the prevention of thromboembolic complications during rehabilitation after spinal cord injury. Both interventions were safe in this population.
这项前瞻性多中心研究比较了低剂量普通肝素(UFH)与依诺肝素在脊髓损伤后康复阶段预防静脉血栓栓塞(VTE)的效果。
在急性期预防2周后,无VTE客观证据的患者进入康复阶段,接受长达6周的额外血栓预防,其中一组每8小时皮下注射UFH 5000 U,另一组每日皮下注射依诺肝素40 mg。之后患者接受双侧下肢重复超声检查。
在119例完成康复阶段且有充分影像学检查的患者中,60例接受UFH治疗的患者中有新增VTE 13例,59例接受依诺肝素治疗的患者中有5例(21.7% 对8.5%;p = 0.052)。每组仅1例患者因出血而退出研究。
在这项非随机对照研究中,依诺肝素在预防脊髓损伤后康复阶段血栓栓塞并发症方面似乎比肝素更有效。两种干预措施在该人群中均安全。